News

QS/1 receives controlled substances e-prescribing certification

BY Alaric DeArment

SPARTANBURG, S.C. — Pharmacy automation provider QS/1 has received certification for controlled substances prescribed electronically, the company said.

QS/1 said it received Electronic Prescriptions for Control Substances certification, making it one of the first pharmacy vendors to certify for EPCS in the 10.6 Script Standard.

"Electronic prescriptions are trending upward," QS/1 marketing and analyst senior manager Michael Ziegler said. "Statistics indicate customers are more likely to have their prescriptions filled and picked up if they are sent electronically."

Implementing EPCS requires software certification from Surescripts and the Drug Enforcement Administration; ComplySmart conducted QS/1’s DEA audit. Pharmacists who receive certification will be able to send prescriptions for controlled substances to pharmacies that use QS/1 software, and the company plans to release EPCS in Service Pack 19.1.12.

"QS/1 also added the ability to accept digital signatures within the QS/1 application," Ziegler said. "This will allow for a more streamlined process when digital signatures are required."


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Teva, Sun to pay $2.15 billion to Pfizer, Takeda to settle Protonix case

BY Alaric DeArment

NEW YORK — Pfizer will receive more than $2 billion from Teva Pharmaceutical Industries and Sun Pharmaceutical Industries to settle a case concerning a gastroesophageal reflux disease drug.

The drug maker said Wednesday that Sun and Teva had agreed to pay $2.15 billion in a patent-infringement suit over the drug Protonix (pantoprazole). The money will compensate Pfizer and Takeda for damages they incurred when Teva and Sun launched "at-risk" generic versions of Protonix in 2007 before the 2011 expiration of a patent covering the drug. Teva will pay $1.6 billion, and Sun will pay $550 million; Pfizer will receive 64% of proceeds.

A federal jury in New Jersey determined that the launches violated U.S. Patent No. 4,758,576, owned by Takeda and licensed to Wyeth, which Pfizer acquired in 2009.


Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Costco cancels Iranian business memberships in Japan, U.K.

BY Alaric DeArment

ISSAQUAH, Wash. — Workers for Iran’s airline and embassy in Japan will have to go somewhere else for their big packages of paper towels.

Costco Wholesale Corp. said it found and canceled four employees of the Embassy of the Islamic Republic of Iran in Japan and two employees of Iran Air in the United Kingdom who had business memberships with the club retailer. The embassy employees spent about $5,497 at the store, while the Iran Air members didn’t spend any money, for a total profit of less than $168.

"The Company does not intend to continue these activities," a quarterly regulatory filing read. The disclosure was made under the Iran Threat Reduction and Syria Human Rights Act of 2012.

Of the club retailer’s 627 stores around the world, 24 are in the United Kingdom, while 15 are in Japan.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?